|
|
Threonine 32 (Thr32) of FoxO3 is critical for TGF-β-induced apoptosis via Bim in hepatocarcinoma cells |
Xiangxuan Zhao1,2,3,*( ),Yong Liu1,2,Lei Du1,2,Leya He4,Biyun Ni1,2,Junbo Hu4,Dahai Zhu5,Quan Chen1,2,6,*( ) |
1. The Joint Laboratory of Apoptosis and Cancer Biology, The State Key Laboratory of Biomembrane and Membrane Biotechnology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China 2. University of Chinese Academy of Sciences, Beijing 100049, China 3. Department of Radiology, Shengjing Hospital of China Medical University, Shenyang 110004, China 4. Cancer Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430032, China 5. Institute of Basic Medical Sciences of Chinese Academy of Medical Sciences and School of Basic Medicine of Peking Union Medical College, Beijing 100005, China 6. College of Life Science, Nankai University, Tianjin 300071, China |
|
|
Abstract Transforming growth factor- β (TGF- β) exerts apoptotic effects on various types of malignant cells, including liver cancer cells. However, the precise mechanisms by which TGF- β induces apoptosis remain poorly known. In the present study, we have showed that threonine 32 (Thr32) residue of FoxO3 is critical for TGF- β to induce apoptosis via Bim in hepatocarcinoma Hep3B cells. Our data demonstrated that TGF- β induced FoxO3 activation through specific de-phosphorylation at Thr32. TGF- β-activated FoxO3 cooperated with Smad2/3 to mediate Bim up-regulation and apoptosis. FoxO3 (de)phosphorylation at Thr32 was regulated by casein kinase I- ? (CKI- ?). CKI inhibition by small molecule D4476 could abrogate TGF- β-induced FoxO/Smad activation, reverse Bim up-regulation, and block the sequential apoptosis. More importantly, the deregulated levels of CKI- ? and p32FoxO3 were found in human malignant liver tissues. Taken together, our findings suggest that there might be a CKI-FoxO/Smad-Bim engine in which Thr32 of FoxO3 is pivotal for TGF- β-induced apoptosis, making it a potential therapeutic target for liver cancer treatment.
|
Keywords
apoptosis
TGF-β
FoxO3
casein kinase I-?
hepatocarcinoma
|
Corresponding Author(s):
Xiangxuan Zhao,Quan Chen
|
Issue Date: 05 February 2015
|
|
1 |
Akagi M, Yasui W, Akama Y, Yokozaki H, Tahara H, Haruma K, Kajiyama G, Tahara E (1996) Inhibition of cell growth by transforming growth factor β1 is associated with p53-independent induction of p21 in gastric carcinoma cells. Jpn J Cancer Res 87: 377-384
https://doi.org/10.1111/j.1349-7006.1996.tb00233.x
|
2 |
Biggs WH III, Cavenee WK, Arden KC (2001) Identification and characterization of members of the FKHR (FOX O) subclass of winged-helix transcription factors in the mouse. Mamm Genome 12: 416-425
https://doi.org/10.1007/s003350020002
|
3 |
<?Pub Caret1?> Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96: 857-868
https://doi.org/10.1016/S0092-8674(00)80595-4
|
4 |
Chen Q, Gong B, Mahmoud-Ahmed AS, Zhou A, Hsi ED, Hussein M, Almasan A (2001) Apo2L/TRAIL and Bcl-2-related proteins regulate type I interferon-induced apoptosis in multiple myeloma. Blood 98: 2183-2192
https://doi.org/10.1182/blood.V98.7.2183
|
5 |
Conery AR, Cao Y, Thompson EA, Townsend CM Jr, Ko TC, Luo K (2004) Akt interacts directly with Smad3 to regulate the sensitivity to TGF-β induced apoptosis. Nat Cell Biol 6: 366-372
https://doi.org/10.1038/ncb1117
|
6 |
Derynck R, Zhang YE (2003) Smad-dependent and Smad-independent pathways in TGF-β family signalling. Nature 425: 577-584
https://doi.org/10.1038/nature02006
|
7 |
Engel ME, Datta PK, Moses HL (1998) RhoB is stabilized by transforming growth factor β and antagonizes transcriptional activation. J Biol Chem 273: 9921-9926
https://doi.org/10.1074/jbc.273.16.9921
|
8 |
Enroth S, Andersson R, Bysani M, Wallerman O, Termen S, Tuch BB, De La Vega FM, Heldin CH, Moustakas A, Komorowski J, Wadelius C (2014) Nucleosome regulatory dynamics in response to TGF-β. Nucleic Acids Res 42: 6921-6934
https://doi.org/10.1093/nar/gku326
|
9 |
Fish KJ, Cegielska A, Getman ME, Landes GM, Virshup DM (1995) Isolation and characterization of human casein kinase I epsilon (CKI), a novel member of the CKI gene family. J Biol Chem 270: 14875-14883
https://doi.org/10.1074/jbc.270.25.14875
|
10 |
Graves PR, Haas DW, Hagedorn CH, Paoli-Roach AA, Roach PJ (1993) Molecular cloning, expression, and characterization of a 49-kilodalton casein kinase I isoform from rat testis. J Biol Chem 268: 6394-6401
|
11 |
Green DR, Reed JC (1998) Mitochondria and apoptosis. Science 281: 1309-1312
https://doi.org/10.1126/science.281.5381.1309
|
12 |
Hagenbuchner J, Kuznetsov A, Hermann M, Hausott B, Obexer P, Ausserlechner MJ (2012) FOXO3-induced reactive oxygen species are regulated by BCL2L11 (Bim) and SESN3. J Cell Sci 125: 1191-1203
https://doi.org/10.1242/jcs.092098
|
13 |
Higaki M, Shimokado K (1999) Phosphatidylinositol 3-kinase is required for growth factor-induced amino acid uptake by vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 19: 2127-2132
https://doi.org/10.1161/01.ATV.19.9.2127
|
14 |
Hua X, Liu X, Ansari DO, Lodish HF (1998) Synergistic cooperation of TFE3 and smad proteins in TGF-β -induced transcription of the plasminogen activator inhibitor-1 gene. Genes Dev 12: 3084-3095
https://doi.org/10.1101/gad.12.19.3084
|
15 |
Huynh H, Nguyen TT, Chan E, Tran E (2003) Inhibition of ErbB-2 and ErbB-3 expression by quercetin prevents transforming growth factor alpha (TGF-alpha)- and epidermal growth factor (EGF)-induced human PC-3 prostate cancer cell proliferation. Int J Oncol 23: 821-829
|
16 |
Karube K, Nakagawa M, Tsuzuki S, Takeuchi I, Honma K, Nakashima Y, Shimizu N, Ko YH, Morishima Y, Ohshima K, Nakamura S, Seto M (2011) Identification of FOXO3 and PRDM1 as tumorsuppressor gene candidates in NK-cell neoplasms by genomic and functional analyses. Blood 118: 3195-3204
https://doi.org/10.1182/blood-2011-04-346890
|
17 |
Kato M, Yuan H, Xu ZG, Lanting L, Li SL, Wang M, Hu MC, Reddy MA, Natarajan R (2006) Role of the Akt/FoxO3a pathway in TGF- β 1-mediated mesangial cell dysfunction: a novel mechanism related to diabetic kidney disease. J Am Soc Nephrol 17: 3325-3335
https://doi.org/10.1681/ASN.2006070754
|
18 |
Knippschild U, Gocht A, Wolff S, Huber N, Lohler J, Stoter M (2005) The casein kinase 1 family: participation in multiple cellular processes in eukaryotes. Cell Signal 17: 675-689
https://doi.org/10.1016/j.cellsig.2004.12.011
|
19 |
Kops GJ, Burgering BM (1999) Forkhead transcription factors: new insights into protein kinase B (c-akt) signaling. J Mol Med (Berl)77: 656-665
https://doi.org/10.1007/s001099900050
|
20 |
Liao XD, Tang AH, Chen Q, Jin HJ, Wu CH, Chen LY, Wang SQ (2003) Role of Ca2+ signaling in initiation of stretch-induced apoptosis in neonatal heart cells. Biochem Biophys Res Commun 310: 405-411
https://doi.org/10.1016/j.bbrc.2003.09.023
|
21 |
Massague J, Weis-Garcia F(1996) Serine/threonine kinase receptors: mediators of transforming growth factor β family signals. Cancer Surv 27: 41-64
|
22 |
Massague J, Seoane J, Wotton D (2005) Smad transcription factors. Genes Dev 19: 2783-2810
https://doi.org/10.1101/gad.1350705
|
23 |
Miyazono K (2000) TGF-beta/SMAD signaling and its involvement in tumor progression. Biol Pharm Bull 23: 1125-1130
https://doi.org/10.1248/bpb.23.1125
|
24 |
Naka K, Hoshii T, Muraguchi T, Tadokoro Y, Ooshio T, Kondo Y, Nakao S, Motoyama N, Hirao A (2010) TGF-β-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia. Nature 463: 676-680
https://doi.org/10.1038/nature08734
|
25 |
Nass SJ, Li M, Amundadottir LT, Furth PA, Dickson RB (1996) Role for Bcl-xL in the regulation of apoptosis by EGF and TGF-β in c-myc overexpressing mammary epithelial cells. Biochem Biophys Res Commun 227: 248-256
https://doi.org/10.1006/bbrc.1996.1497
|
26 |
Ni YG, Wang N, Cao DJ, Sachan N, Morris DJ, Gerard RD, Kuro O, Rothermel BA, Hill JA (2007) FoxO transcription factors activate Akt and attenuate insulin signaling in heart by inhibiting protein phosphatases. Proc Natl Acad Sci U S A 104: 20517-20522
https://doi.org/10.1073/pnas.0610290104
|
27 |
Park JT, Kato M, Yuan H, Castro N, Lanting L, Wang M, Natarajan R (2013) FOG2 protein down-regulation by transforming growth factor-β1-induced microRNA-200b/c leads to Akt kinase activation and glomerular mesangial hypertrophy related to diabetic nephropathy. J Biol Chem 288: 22469-22480
https://doi.org/10.1074/jbc.M113.453043
|
28 |
Philips N, McFadden K (2004) Inhibition of transforming growth factor-β and matrix metalloproteinases by estrogen and prolactin in breast cancer cells. Cancer Lett 206: 63-68
https://doi.org/10.1016/j.canlet.2003.10.019
|
29 |
Qi W, Weber CR, Wasland K, Roy H, Wali R, Joshi S, Savkovic SD (2011a) Tumor suppressor FOXO3 mediates signals from the EGF receptor to regulate proliferation of colonic cells. Am J Physiol Gastrointest Liver Physiol 300: G264-G272
https://doi.org/10.1152/ajpgi.00416.2010
|
30 |
Qi W, Weber CR, Wasland K, Savkovic SD (2011b) Genistein inhibits proliferation of colon cancer cells by attenuating a negative effect of epidermal growth factor on tumor suppressor FOXO3 activity. BMC Cancer 11: 219
https://doi.org/10.1186/1471-2407-11-219
|
31 |
Ramjaun AR, Tomlinson S, Eddaoudi A, Downward J (2007) Upregulation of two BH3-only proteins, Bmf and Bim, during TGF beta-induced apoptosis. Oncogene 26: 970-981
https://doi.org/10.1038/sj.onc.1209852
|
32 |
Remy I, Montmarquette A, Michnick SW (2004) PKB/Akt modulates TGF-β signalling through a direct interaction with Smad3. Nat Cell Biol 6: 358-365
https://doi.org/10.1038/ncb1113
|
33 |
Renard E, Chadjichristos C, Kypriotou M, Beauchef G, Bordat P, Dompmartin A, Widom RL, Boumediene K, Pujol JP, Galera P (2008) Chondroitin sulphate decreases collagen synthesis in normal and scleroderma fibroblasts through a Smad-independent TGF-β pathway—implication of C-Krox and Sp1. J Cell Mol Med 12: 2836-2847
https://doi.org/10.1111/j.1582-4934.2008.00287.x
|
34 |
Renault VM, Thekkat PU, Hoang KL, White JL, Brady CA, Kenzelmann BD, Venturelli OS, Johnson TM, Oskoui PR, Xuan Z, Santo EE, Zhang MQ, Vogel H, Attardi LD, Brunet A (2011) The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor. Oncogene 30: 3207-3221
https://doi.org/10.1038/onc.2011.35
|
35 |
Runyan CE, Liu Z, Schnaper HW (2012) Phosphatidylinositol 3-kinase and Rab5 GTPase inversely regulate the Smad anchor for receptor activation (SARA) protein independently of transforming growth factor-β 1. J Biol Chem 287: 35815-35824
https://doi.org/10.1074/jbc.M112.380493
|
36 |
Seoane J, Le HV, Massague J (2002) Myc suppression of the p21 (Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature 419: 729-734
https://doi.org/10.1038/nature01119
|
37 |
Torregroza I, Evans T (2006) Tid1 is a Smad-binding protein that can modulate Smad7 activity in developing embryos. Biochem J 393: 311-320
https://doi.org/10.1042/BJ20050785
|
38 |
Tremblay ML, Giguere V (2008) Phosphatases at the heart of FoxO metabolic control. Cell Metab 7: 101 -103
https://doi.org/10.1016/j.cmet.2008.01.004
|
39 |
Tuazon PT, Traugh JA (1991) Casein kinase I and II–multipotential serine protein kinases: structure, function, and regulation. Adv Second Messenger Phosphoprotein Res 23: 123-164
|
40 |
Valderrama-Carvajal H, Cocolakis E, Lacerte A, Lee EH, Krystal G, Ali S, Lebrun JJ (2002) Activin/TGF-β induce apoptosis through Smad-dependent expression of the lipid phosphatase SHIP. Nat Cell Biol 4: 963-969
https://doi.org/10.1038/ncb885
|
41 |
Vignais ML (2000) Ski and SnoN: antagonistic proteins of TGF-β signaling. Bull Cancer 87: 135-137
|
42 |
Vogt PK, Jiang H, Aoki M (2005) Triple layer control: phosphorylation, acetylation and ubiquitination of FOXO proteins. Cell Cycle 4: 908-913
https://doi.org/10.4161/cc.4.7.1796
|
43 |
Waddell DS, Liberati NT, Guo X, Frederick JP, Wang XF (2004) Casein kinase Iepsilon plays a functional role in the transforming growth factor-β signaling pathway. J Biol Chem 279: 29236-29246
https://doi.org/10.1074/jbc.M400880200
|
44 |
Wildey GM, Howe PH (2009) Runx1 is a co-activator with FOXO3 to mediate transforming growth factor β (TGF-β )-induced Bim transcription in hepatic cells. J Biol Chem 284: 20227-20239
https://doi.org/10.1074/jbc.M109.027201
|
45 |
Yamamura Y, Hua X, Bergelson S, Lodish HF (2000) Critical role of Smads and AP-1 complex in transforming growth factor-β -dependent apoptosis. J Biol Chem 275: 36295-36302
https://doi.org/10.1074/jbc.M006023200
|
46 |
Yan L, Lavin VA, Moser LR, Cui Q, Kanies C, Yang E (2008) PP2A regulates the pro-apoptotic activity of FOXO1. J Biol Chem 283: 7411-7420
https://doi.org/10.1074/jbc.M708083200
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|